Last reviewed · How we verify
Omega-3 2g
At a glance
| Generic name | Omega-3 2g |
|---|---|
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Total GI Disorders
- Nausea
- Diarrhea
- Total Musculoskeletal Disorders
- Eructation
- Total Injury
- Total Infections
- Arthralgia
- Total Nervous System Disorders
- Dyspepsia
- Flatulence
- Urinary Tract infection
Key clinical trials
- A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function (NA)
- Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial (PHASE2)
- Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial (NA)
- Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+. (PHASE4)
- Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes (PHASE4)
- Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia (PHASE2)
- Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia (PHASE3)
- Effects of Fish Oil and Resistance Training on Muscle Mass and Function (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |